Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
11 |
Material Type: Artigo
|
![]() |
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trialvan Schaik, Ivo N ; Bril, Vera ; van Geloven, Nan ; Lewis, Richard A ; Sobue, Gen ; Lawo, John-Philip ; Mielke, Orell ; Durn, Billie L ; Cornblath, David R ; George, K. ; Henderson, R. ; Van Damme, P. ; Demeestere, J. ; Larue, S. ; D'Amour, C. ; Breiner, A. ; Kunc, P. ; Sussova, J. ; Kalous, T. ; Talab, R. ; Bednar, M. ; Toomsoo, T. ; Sorro, U. ; Saarela, M. ; Auranen, M. ; Pouget, J. ; Attarian, S. ; Le Masson, G. ; Wielanek-Bachelet, A. ; Delmont, E. ; Aufauvre, D. ; Sommer, C. ; Kramer, D. ; Goerlitz, C. ; Haas, J. ; Chatzopoulos, M. ; Gold, R. ; Jaspert-Grehl, A. ; Kutschenko, A. ; Trebst, C. ; Baum, P. ; Bergh, F. ; Klehmet, J. ; Klostermann, F. ; Oechtering, J. ; Schroeter, M. ; Mueller, D. ; Sperfeld, A. ; Drory, V. ; Algom, A. ; Yarnitsky, D. ; Murinson, B. ; Ciccocioppo, F. ; Grandis, M. ; Lauria, G. ; Cazzato, D. ; Antonini, G. ; Morino, S. ; Cocito, D. ; Zibetti, M. ; Yokota, T. ; Ohkubo, T. ; Kanda, T. ; Kaida, K. ; Onoue, H. ; Kuwabara, S. ; Mori, M. ; Iijima, M. ; Baba, M. ; Yokoyama, K. ; van Schaik, I.N. ; Visser, N. ; Hoeijmakers, J. ; Rejdak, K. ; Casanovas Pons, C. ; Alberti Aguiló, M. ; Figueras, M. ; Marquez Infante, C. ; Benitez Rivero, S. ; Lunn, M. ; Morrow, J. ; Lavin, T. ; Melamed, I. ; Ajroud-Driss, S. ; Menichella, D. ; Dimachkie, M. ; Beydoun, S. ; Johl, H. ; Shtilbans, A. ; Ladha, S. ; Freimer, M. ; Kissel, J. ; Latov, N. ; Ubogu, E. ; Rao, T. ; Sharma, K. ; Gonzalez, G. ; Allen, J. ; Walk, D. ; Hobson-Webb, L.Lancet neurology, 2018-01, Vol.17 (1), p.35-46 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
12 |
Material Type: Artigo
|
![]() |
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trialsGordon, Kenneth B ; Strober, Bruce ; Lebwohl, Mark ; Augustin, Matthias ; Blauvelt, Andrew ; Poulin, Yves ; Papp, Kim A ; Sofen, Howard ; Puig, Lluís ; Foley, Peter ; Ohtsuki, Mamitaro ; Flack, Mary ; Geng, Ziqian ; Gu, Yihua ; Valdes, Joaquin M ; Thompson, Elizabeth H Z ; Bachelez, HervéThe Lancet (British edition), 2018-08, Vol.392 (10148), p.650-661 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
13 |
Material Type: Artigo
|
![]() |
Subcutaneous immunoglobulin treatment in CIDP and MMN. Efficacy, treatment satisfaction and costsMarkvardsen, Lars H ; Harbo, ThomasJournal of the neurological sciences, 2017-07, Vol.378, p.19-25 [Periódico revisado por pares]Netherlands: Elsevier B.VTexto completo disponível |
14 |
Material Type: Artigo
|
![]() |
Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiencyWasserman, Richard L., MD, PhD ; Melamed, Isaac, MD ; Stein, Mark R., MD ; Gupta, Sudhir, MD, PhD ; Puck, Jennifer, MD ; Engl, Werner, PhD ; Leibl, Heinz, PhD ; McCoy, Barbara, PhD ; Empson, Victoria G., MSc (Hons) ; Gelmont, David, MD ; Schiff, Richard I., MD, PhDJournal of allergy and clinical immunology, 2012-10, Vol.130 (4), p.951-957.e11 [Periódico revisado por pares]New York, NY: Mosby, IncTexto completo disponível |
15 |
Material Type: Artigo
|
![]() |
Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapyShamji, M. H. ; Ljørring, C. ; Francis, J. N. ; A Calderon, M. ; Larché, M. ; Kimber, I. ; Frew, A. J. ; Ipsen, H. ; Lund, K. ; Würtzen, P. A. ; Durham, S. R.Allergy (Copenhagen), 2012-02, Vol.67 (2), p.217-226 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
16 |
Material Type: Artigo
|
![]() |
Population pharmacokinetic simulation of varied Immune Globulin Subcutaneous (Human), 20% solution (Ig20Gly) loading and maintenance dosing regimens in immunoglobulin-naïve patients with primary immunodeficiency diseasesLi, Zhaoyang ; Dumas, Todd ; Seth Berry, N. ; McCoy, Barbara ; Yel, LemanInternational immunopharmacology, 2021-11, Vol.100, p.108044, Article 108044 [Periódico revisado por pares]Netherlands: Elsevier B.VTexto completo disponível |
17 |
Material Type: Artigo
|
![]() |
Facilitated subcutaneous immunoglobulin (fSCIg) therapy – practical considerationsPonsford, M. ; Carne, E. ; Kingdon, C. ; Joyce, C. ; Price, C. ; Williams, C. ; El‐Shanawany, T. ; Williams, P. ; Jolles, S.Clinical and experimental immunology, 2015-12, Vol.182 (3), p.302-313 [Periódico revisado por pares]England: Oxford University PressTexto completo disponível |
18 |
Material Type: Artigo
|
![]() |
Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trialVacca, Angelo ; Melaccio, Assunta ; Sportelli, Azzurra ; Solimando, Antonio G. ; Dammacco, Franco ; Ria, RobertoClinical immunology (Orlando, Fla.), 2018-06, Vol.191, p.110-115 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
19 |
Material Type: Artigo
|
![]() |
Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficienciesBerger, Melvin ; Rojavin, Mikhail ; Kiessling, Peter ; Zenker, OthmarClinical immunology (Orlando, Fla.), 2011-05, Vol.139 (2), p.133-141 [Periódico revisado por pares]Amsterdam: Elsevier IncTexto completo disponível |
20 |
Material Type: Artigo
|
![]() |
Immunoglobulin Replacement Therapy for Primary ImmunodeficiencySriaroon, Panida, MD ; Ballow, Mark, MDImmunology and allergy clinics of North America, 2015-11, Vol.35 (4), p.713-730 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |